In a prospective targeted sequencing involving 1134 CRC samples, mutations in adenomatous polyposis coli (APC) and CTNNB1 genes were identified, which increased oncogenic WNT pathway changes to 96% of CRCs [8]. This evidence concerns the gene APC and colorectal carcinoma.